HDAC2 and chronic obstructive pulmonary disease: In terms of airway disease, the drug theophylline, which exerts it effects by activating HDAC2, is used to treat patients with corticosteroid resistant chronic obstructive pulmonary disease and has the potential to treat corticosteroid insensitive asthmatics [56–58].